News | Catheter | January 31, 2023

Medtronic Recalls Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters for Potential Catheter Hub Defect

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death 

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death

January 31, 2023 — The U.S. Food and Drug Administration (FDA) issued a statement announcing that Medtronic is recalling the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters due to a potential catheter hub defect that may cause leaks across the catheter’s tubes. During treatment, this leak could result in mixing of the arterial and venous blood, lead to increased recirculation and poor dialysis, or cause the development of blood clots in the blood vessels. 

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. 

Recalled Product  

Product Name: Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus)  

Product Models: See Medical Device Recall Database entry 

Distribution Dates: March 19, 2022 to September 2, 2022 

Devices Recalled in the U.S.: 22,763 

Date Initiated by Firm: November 23, 2022 

Device Use 

Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters are implanted and used in hemodialysis (treatment to filter waste and water from the blood), apheresis (a technology that separates donated blood components to treat certain illnesses), and infusion (a method of putting fluids into the bloodstream) for up to 21 days. 

Reason for Recall  

Medtronic is recalling the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters due to a potential catheter hub defect that may cause leaks across the catheter’s tubes. During treatment, this leak could result in mixing of the arterial and venous blood, lead to increased recirculation and poor dialysis, or cause the development of blood clots in the blood vessels.  

The use of the defective catheter may cause serious adverse health outcomes, including bleeding or the need for surgical removal and replacement of the affected catheter. 

There have been two injuries reported related to this issue and no reports of death.  

Who May be Affected  

  • People who receive care using the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters 
  • Health care personnel providing care using the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters 

What to Do  

On December 07, 2022, Medtronic sent customers an Urgent Medical Device Recall letter. The letter recommended the following actions:  

For Devices Currently in Use 

  • Continue to follow facility specific policies and procedures for routine assessment of the hemodialysis access device for patency, function, and efficacy. 
  • Clinicians should look for visible ‘communication’ or movement of catheter contents between the venous and arterial lumens within the catheter. It will not present as an external leak or defect. 
  • If the issue is detected, the patient’s medical team should use their clinical judgement in determining the necessity and timing of a replacement catheter in accordance to the product Instructions For Use and facility specific policies and procedures. 

For All Devices 

  • Visit MedtronicExternal Link Disclaimer to access a tool to help determine if product is affected by this recall. Note: The affected devices are located within a kit, IC tray, or PASS tray. 
  • Immediately quarantine and discontinue use of all unused Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters from affected lots. 
  • Complete the Customer Confirmation Form (even if affected product is no longer on hand) and email the completed form to: 
  • Recall Department [email protected]  
  • Customer Service [email protected] and request a Return Good Authorization (RGA) number.  
  • Return all unused affected Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters to Medtronic per the company’s instructions with the RGA number received from Customer Service.  
  • Notify any recipients of distributed Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters. 
  • Share this notice with the organization’s nephrologists, physicians, renal nurses, other dialysis or clinical staff who need to be aware. 

Contact Information  

Customers with questions about this recall should contact their Medtronic representative or call Customer Service at 800-962-9888, option 2.  

Additional Resources:  

 

How do I report a problem? 

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX. 


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now